In Vivo-Assembled Artificial Base-Albumin Platform for Tumor-Targeted General Drug Delivery
ACS Nano · 2026
DOI: 10.1021/acsnano.5c18497 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2026. Verfasst von Die Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engi…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Drug Delivery Systems, Albumins, Drug Carriers. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Innovative Research Team of High-level Local University in Shanghai.
Abstract (Originalsprache)
Chemotherapy can lead to severe side effects owing to drug accumulation in normal tissues and organs. As a countermeasure, targeted drug delivery strategies have been developed, including albumin-PTX (nab-PTX) approved by the FDA. Previously, we reported an artificial nucleobase containing fluorine, the F-base, which can interact with albumin for oligonucleotide tumor-targeted delivery. Here, we systematically assessed the potential of an in vivo-assembled platform for the delivery of tumor-targeted chemotherapeutic drugs, whereby molecular precursors self-assembled into nanostructures at the tumor site. Chemotherapeutic drugs, including 5-fluorouracil, gemcitabine, and monomethyl auristatin E, were first incorporated into oligonucleotides, a targeting molecule, to form a drug-loaded DNA sequence. Subsequent introduction of an F-base at both ends of the targeting molecule resulted in enhanced therapeutic potential. The assembly of F-drugs combined with albumin was characterized and verified, and the cytotoxicity, biodistribution, pharmacokinetics, therapeutic efficiency, and biosafety were analyzed. The results showed that the F-base modification improved drug stability, penetrability, and cytotoxicity in vitro. Longer circulation times, higher tumor enrichment, and improved antitumor effects were observed in CDX, PDX, and murine orthotopic tumor model. Together, the findings introduce an F-based delivery system that boosts both the solubility and tumor penetration of chemotherapeutics, offering a promising approach for targeted cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, College of Biology, Aptamer Engineering Center of Hunan Provi…
- Institute of Molecular Medicine (IMM), Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200240, China.
- Department of Oncology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai200127, China.
- Zhejiang Cancer Hospital, The Key Laboratory of Zhejiang Province for Aptamers and Theranostics, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China.
ORCID-Profile: Xue-Qiang Wang, Ruowen Wang, Yang Sun
Förderung
- National Key Research and Development Program of China
- Innovative Research Team of High-level Local University in Shanghai
Zitieren
APA
Yu, D., Chen, S., Xu, M., Xu, H., Wang, X. Q., Wang, R., Sun, Y., & Tan, W. (2026). In Vivo-Assembled Artificial Base-Albumin Platform for Tumor-Targeted General Drug Delivery. ACS Nano. https://doi.org/10.1021/acsnano.5c18497
Vancouver
Yu D, Chen S, Xu M, Xu H, Wang XQ, Wang R, et al. In Vivo-Assembled Artificial Base-Albumin Platform for Tumor-Targeted General Drug Delivery. ACS Nano. 2026. doi:10.1021/acsnano.5c18497
BibTeX
@article{Yu2026,
author = {Yu, Die and Chen, Shuangya and Xu, Mingxin and Xu, Haiyan and Wang, Xue-Qiang and Wang, Ruowen and Sun, Yang and Tan, Weihong},
title = {In Vivo-Assembled Artificial Base-Albumin Platform for Tumor-Targeted General Drug Delivery},
journal = {ACS Nano},
year = {2026},
doi = {10.1021/acsnano.5c18497}
}
EUVIMED